Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Unless you spend your free time watching hours of C-SPAN, the odds are you aren’t too keenly aware of the inner workings of Congress and instead rely on hysterical headlines from MSNBC, Fox News and ...
Joe Trippi pioneered the use of social media as a fundraising tool. As campaign manager for Democratic presidential candidate Howard Dean in 2004, he started a trend that has reinvented that way ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics Countable Labs, the ...
Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. February 21, 2017 Add ...
Countable Labs has raised $26m to advance the development and commercialisation activities for its single-molecule polymerase chain reaction (PCR) technology. The California-based company’s financing ...
Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in ...
Enterprise engagement company Countable raised $12 million in Series A funding so that brands can more easily engage with customers, even in a way that shows a brand’s values and stance on issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results